Marcel Botha, CEO of 10XBeta, discusses FDA’s new pilot authorization program for abbreviated new drug applications (ANDA) ...

PE: What impact will DTC programs have on generic drug prices? O’Dell: Not much today, but generics are not completely immune ...

Eli Lilly and Walmart Pharmacy collaborate to offer Zepbound vials through LillyDirect, enhancing patient access and convenience. Patients with valid prescriptions can access Zepbound without ...

Shortly following the announcement of its acquisition of Syndivia’s ADC, GSK entered into a worldwide exclusive license ...

In today’s Pharmaceutical Executive Daily, we cover the resignation of Organon CEO Kevin Ali following an internal investigation tied to Nexplanon sales, GSK’s $357 million agreement with Syndivia to ...

Zag Bio announced the company’s launch with a $80 million financing round, which includes a recently closed Series A ...

The FDA has approved a new single-injection, once-monthly maintenance regimen for Eli Lilly’s Omvoh (mirikizumab-mrkz), ...

GSK is set to acquire the exclusive rights for Syndivia’s preclinical antibody-drug conjugate (ADC), which is currently in ...

Novartis will acquire Avidity Biosciences in a newly announced definitive merger agreement. The news follows the separation ...

Organon announced that CEO Kevin Ali intends to resign from his position following results from an internal investigation ...

Obesity is a complex, treatable medical condition, not just a matter of willpower, requiring a shift in perception and ...

Biologic age is determined by measuring how well the body’s cells and organs are functioning. This is different than ...